当前位置:首页 - 行情中心 - 健帆生物(300529) - 财务分析

健帆生物

(300529)

  

流通市值:99.50亿  总市值:155.33亿
流通股本:5.12亿   总股本:7.99亿

健帆生物(300529)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润4.52亿元,每股收益0.59元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益342865.46万元,未分配利润234806.79万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产553610.06万元,负债210744.60万元。

利润表
报告期2025-09-302025-06-302025-03-312024-12-31
营业总收入1,556,021,993.541,134,416,582.38547,835,977.142,677,320,710.76
营业总成本1,020,308,100.76691,481,834.59331,034,826.71,711,410,834.56
其他经营收益
营业利润586,380,633.08481,171,504.06236,505,672.181,045,365,774.88
利润总额552,053,862.95461,903,988.17225,129,406.851,006,964,187.92
净利润451,858,349.46388,668,556.92188,177,307.35814,186,376.79
每股收益
其他综合收益---1,054,450.84
综合收益总额451,858,349.46388,668,556.92188,177,307.35815,240,827.63
资产负债表
报告期2025-09-302025-06-302025-03-312024-12-31
流动资产:
流动资产合计2,915,854,287.42,634,307,821.893,073,800,310.582,783,662,467.05
非流动资产:
非流动资产合计2,620,246,316.852,632,959,589.592,609,626,928.292,599,786,609.41
资产总计5,536,100,604.255,267,267,411.485,683,427,238.875,383,449,076.46
流动负债:
流动负债合计685,205,805.61739,598,918.35779,769,719.98766,793,322.83
非流动负债:
非流动负债合计1,422,240,153.751,405,250,0031,371,528,176.231,281,991,218.31
负债合计2,107,445,959.362,144,848,921.352,151,297,896.212,048,784,541.14
所有者权益(或股东权益):
归属于母公司股东权益合计3,429,268,141.053,122,714,168.663,531,977,322.493,333,906,225.54
股东权益合计3,428,654,644.893,122,418,490.133,532,129,342.663,334,664,535.32
负债和股东权益合计5,536,100,604.255,267,267,411.485,683,427,238.875,383,449,076.46
现金流量表
报告期2025-09-302025-06-302025-03-312024-12-31
经营活动产生的现金流量:
经营活动现金流入小计1,865,890,761.171,402,751,627.12658,571,672.873,031,200,823.77
经营活动现金流出小计1,292,650,606864,470,191.73389,517,884.061,980,212,402.37
经营活动产生的现金流量净额573,240,155.17538,281,435.39269,053,788.811,050,988,421.4
投资活动产生的现金流量:
投资活动现金流入小计1,930,802,969.431,788,774,548.16651,287,207.783,780,380,657.98
投资活动现金流出小计3,173,223,187.592,678,769,929.412,182,381,942.84,907,852,936.29
投资活动产生的现金流量净额-1,242,420,218.16-889,995,381.25-1,531,094,735.02-1,127,472,278.31
筹资活动产生的现金流量:
筹资活动现金流入小计528,230,606.273,948,636.4843,071,108.07419,418,426.61
筹资活动现金流出小计1,124,700,280.94701,421,484.3427,128,528.121,409,239,488.08
筹资活动产生的现金流量净额-596,469,674.74-627,472,847.8615,942,579.95-989,821,061.47
汇率变动对现金及现金等价物的影响-525,067.8593,947.11145,379.17427,871.75
现金及现金等价物净增加额-1,266,174,805.58-979,092,846.61-1,245,952,987.09-1,065,877,046.63
期末现金及现金等价物余额409,491,435.67696,573,394.64429,713,254.161,675,666,241.25
补充资料:
现金及现金等价物的净增加额--979,092,846.61--1,065,877,046.63
最新报告期:2025-10-29
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
国金证券何冠洲0.740.951.122025-10-29
华泰证券代雯,高鹏,杨昌源0.690.760.842025-10-29
TOP↑